NZ245526A - Pharmaceutical compositions and animal feedstuffs containing coarsely-particulate cereal bran as carrier - Google Patents

Pharmaceutical compositions and animal feedstuffs containing coarsely-particulate cereal bran as carrier

Info

Publication number
NZ245526A
NZ245526A NZ245526A NZ24552692A NZ245526A NZ 245526 A NZ245526 A NZ 245526A NZ 245526 A NZ245526 A NZ 245526A NZ 24552692 A NZ24552692 A NZ 24552692A NZ 245526 A NZ245526 A NZ 245526A
Authority
NZ
New Zealand
Prior art keywords
active compound
compound preparation
bran
carrier
middlings
Prior art date
Application number
NZ245526A
Inventor
Arnd Blecher
Rudiger Hoffmann
Theophil Hornykiewytsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ245526A publication Critical patent/NZ245526A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number £45526 <br><br> 245526 <br><br> Patents Form 5 <br><br> r av- <br><br> rv^ss: CV«v&gt;W-tr&gt;\^*W. £V23*VA\\&gt;o. <br><br> ; Publication Dare: ... 2.6. JUL.1995.. ?.0. Journal. Mo: ,.l3£V&lt;fc-. <br><br> NQ DP WMf/s't* <br><br> ■■w (urnmyilytyQ <br><br> N.Z. No. <br><br> NEW ZEALAND Patents Act 1953 COMPLETE SPECIFICATION <br><br> PHARMACEUTICAL AND FEEDSTUFF PREM1XES <br><br> We. HOECHST AKTIENGESELLSCHAFT, a Joint Stock Company existing under the laws of the Federal Republic of Germany, of D-6230 Frankfurt am Main 80, Federal Republic of Germany do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:- <br><br> - I - (Followed by 1A) <br><br> r» r r~ o f- <br><br> - 1A - <br><br> HUJLlflST 'P &lt;11 '81 .ABj'aUl' <br><br> Description <br><br> ~ Pharmaceutical and feedstuff premixes <br><br> In livestock farming, in particular intensive livestock farming, premixes play an important role in the adminis-5 tration of pharmaceuticals and feed additives. Premixes are concentrated mixtures of the pharmaceutical, or of the feed additive, with one or more carriers. Before they are administered to the animals, they are extended by the user to the use concentration. To avoid separation of the 10 mixtures, and thus inhomogeneity in the end mixture, during transport and mixing at the user's, the physical properties of the premix must meet high demands. The properties of the premix, mainly flowability, mixability, separation behavior of the mixture, dust count and 15 tendency to caking under pressure are determined by the carrier, or carriers, which generally make up more than 90 % of the premix. Selection of the suitable carrier is therefore of crucial importance for the quality of the premix. <br><br> 20 The manufacturer of a stable premix will strive to optimize the range of demands with regard to quality, having had the problem that, for example, admixing coarse cereal particles improve the flowability properties, but . adversely affect the stability of the mixture (IFF-Dienst <br><br> — 25 No. 221, Institut fur Futtermittelforschung [Institute of Feedstuffs Research], Braunschweig-Thune, January/February 1990). <br><br> This is so because separation of the mixture can take place when the carrier is composed of particles of 30 different sizes. This separation process of the mixture is favored the greater the difference in particle size is, since the small particles are capable of falling through the interstices of the large particles. The predominant school of thought therefore proposes to 35 produce premixes of carriers and active substances having <br><br> 245526 <br><br> - 2 - <br><br> the same small particle size. The tendency of the mixture to separate can be prevented in this manner, however, other negative properties such as reduced flowability and increased dust count, will have to be accepted. <br><br> 5 Surprisingly, it has been found that coarsely-particulate carriers show no greater separation of the mixture than finely-particulate ones. Compared with premixes with finely-particulate carriers, premixes with coarsely-particulate carriers show markedly better physical 10 properties. The flowability is improved, there is no measurable development of dust, and caking under pressure is reduced. <br><br> This means that the use of coarsely-particulate carriers can solve the problems which occur in the manufacture of 15 premixes in a satisfactory manner. <br><br> The invention relates to an active compound preparation which comprises one or more active compounds (pharmaceutical additives and feed additives) and coarsely-particulate cereal bran as carrier. This active compound 20 preparation is a pharmaceutical or feedstuff premix. <br><br> Moreover, the invention relates to a process for manufacturing this active compound preparation which comprises intimately mixing the active compound and the carrier. <br><br> A suitable coarsely-particulate cereal bran is preferably 25 cereal bran having a particle size fraction &gt; 250 ^m of at least 90 %, in particular durum and aestivum wheat middlings bran, such as coarsely-particulate wheat middlings bran WG 12. <br><br> The term active compound embraces pharmaceutical addi-30 tives and feed additives. These are known in principle and are described, for example, in the Arzneimittelgesetz ,r. [Pharmaceutical Act] (§2) and in the Futtermittelgesej^t*1 °' vV <br><br> [Feedstuffs Act] (§2). ^ <br><br> r ^ <br><br> * <br><br> - 3 - <br><br> 245526 <br><br> compounds which can be added to the carrier are, for example, coccidiostats, anthelmintics, antibiotics, minerals, vitamins and performance promoters. Performance promoters are to be understood as meaning those compounds which affect the growth, metabolism, body weight, tissue composition and/or feed conversion, for example sulazuril, halofuginon, salinomycin sodium and flavophos-pholipol, in particular sulazuril. <br><br> The examples which follow are intended to illustrate the invention, particularly in its preferred embodiments. The invention is furthermore determined by the contents of the patent claims. Unless otherwise indicated, percentages are by weight. <br><br> 1. Test for separation behavior of the mixture <br><br> The separation behavior of the mixture was tested by allowing the homogeneous premix to run along a vibration channel and forming a poured cone. Samples were taken from the tip and the foot of the cone and analyzed. Deviations from the desired value of the homogeneous premix are indicators for separation of the mixture during transport along the vibration channel or during free fall. <br><br> In a plough-share mixer, 99 parts of carrier were mixed with one part of active compound (sulazuril). After 5, 10 and 15 minutes, samples were taken from different locations of the mixer and analyzed. <br><br> 245526 <br><br> - 4 - <br><br> Content of active compound sulazuril (INN): <br><br> 10 <br><br> Sampling site <br><br> 5 min <br><br> 10 min <br><br> 15 min <br><br> a b <br><br> a b <br><br> a b <br><br> 1 <br><br> 0.98 <br><br> 0.99 <br><br> 1.00 <br><br> 1.01 <br><br> 0.99 <br><br> 1.01 <br><br> 2 <br><br> 0.99 <br><br> 0.99 <br><br> 0.99 <br><br> 1.00 <br><br> 0.99 <br><br> 0.99 <br><br> 3 <br><br> 1.00 <br><br> 1.01 <br><br> 0.99 <br><br> 1.01 <br><br> 0.99 <br><br> 1.00 <br><br> a) Fine wheat middlings bran (70 % &lt; 250 nm) <br><br> b) WG 12 <br><br> 15 <br><br> 20 <br><br> Separation of the mixture of the transport along vibration channel: <br><br> Vibration channel: length 45 cm, pouring height: 15 cm Active compound content: Fine wheat middlings bran WG 12 <br><br> Tip of the cone Foot of the cone <br><br> 1.03 1.02 <br><br> 1.00 0.99 <br><br> Separation of the mixture after tamping: 250 ml tamping cylinder, 1250 strokes <br><br> 25 <br><br> Active compound <br><br> Surface <br><br> Bottom content Fine wheat middlings bran WG 12 <br><br> 1.03 1.01 <br><br> 1.02 0.99 <br><br> Neither during transport along the vibration channel nor during tamping, does the use of coarse wheat middlings bran result in separation of the premix. <br><br> 2. Determination of the dust count <br><br> 30 The dust count was determined using an automated dust counter. The apparatus is composed of the gauging box with a dust box inside. A downpipe 50 cm in length wi an extending feed tube and hopper is attached to the b&lt; <br><br> / <br><br></p> </div>

Claims (12)

<div class="application article clearfix printTableText" id="claims"> <p lang="en"> At the bottom, the feed tube is separated from the down-pipe by means of a flap to be opened magnetically. On opening, the entire cross-section of the tube is uncovered for 2 seconds. In the gauging box, an illumi-5 nation (12 V, 15 W) and a selenium photocell (S 60, manufactured by Bruno Lange) are attached collaterally and offset with regard to the direction of falling, both of which as well as the magnetic flap are connected to the apparatus by separate leads. The apparatus is 10 designed for a supply voltage of 220 V, and the voltage is stabilized to ± 0.1 %.<br><br> On measuring, a peak value memory records the peak value, stores it and, after a measuring period of 30 seconds, adds it to the momentary value. This is the end of the 15 measurement. The dust count is the total of the peak value and the value after 30 seconds.<br><br> The dust count of fine wheat middlings bran was: 1.6/1.4; the dust count of the coarse wheat middlings bran (WG 12) was 0.<br><br> 20 3. Test for caking<br><br> The test method for determining the caking tendency ia described by Russow et al. in Chem. Ing.-Techn. 40th volume 1968/No. 4, page 191.<br><br> The data were 4.1/3.8 kg in the case of fine wheat 25 middlings bran and 1.4/2.0 kg in the case of coarse wheat middlings bran (WG 12) (2 determinations).<br><br> 24 5 b Z o<br><br> 6<br><br> WHAT WE CLAIM IS:<br><br>
1. An active compound preparation which comprises one or more active compounds (pharmaceutical additives and feed additives) and coarsely particulate cereal bran (having a particle size distribution &gt; 250 nm of at least 90% by weight) as carrier, said active compound preparation comprising a pharmaceutical or feedstuff premix.<br><br>
2. An active compound preparation as claimed in claim 1, wherein the carrier is composed of wheat middlings bran.<br><br>
3. An active compound preparation as claimed in claim 1 or 2, wherein the active compound is selected from vitamins, and performance promoters, performance promoters meaning those compounds which affect one or more of growth metabolism, body weight, tissue composition and feed conversion.<br><br>
4. An active compound preparation as claimed in any one of claims 1 to 3, wherein the active compound is a coccidiostat.<br><br>
5. An active compound preparation as claimed in any one of claims l to 3, wherein sulazuril is employed as active compound.<br><br>
6. An active compound preparation as claimed in any one of claims l to 4 for use in the treatment and prophylaxis of parasitosis.<br><br>
7. An active compound preparation according to c<br><br> /<br><br> wherein the parasitosis is coccidiosis.<br><br> r.<br><br> ' *• "1 .. /<br><br> mS26<br><br> 7<br><br>
8. Use of an active compound preparation, as claimed in any one of claims l to 6, in non-human animal nutrition and for non-human animal health.<br><br>
9. Use of an active compound preparation according to claim 8, wherein the active compound is a coccidiostat.<br><br>
10. A process for manufacturing an active compound preparation as claimed in any one of claims 1 to 5, which comprises intimately mixing the carrier with the active compound.<br><br>
11. An active compound preparation according to claim 1 substantially as herein described or exemplified.<br><br>
12. A process according to claim 10 substantially as herein described or exemplified.<br><br> HOECHST AKTIENGESELLSCHAFT By their attorneys HENRY HUGHES<br><br> Per:<br><br> </p> </div>
NZ245526A 1991-12-21 1992-12-18 Pharmaceutical compositions and animal feedstuffs containing coarsely-particulate cereal bran as carrier NZ245526A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4142633 1991-12-21

Publications (1)

Publication Number Publication Date
NZ245526A true NZ245526A (en) 1995-07-26

Family

ID=6447923

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ245526A NZ245526A (en) 1991-12-21 1992-12-18 Pharmaceutical compositions and animal feedstuffs containing coarsely-particulate cereal bran as carrier

Country Status (14)

Country Link
EP (1) EP0549975A1 (en)
JP (1) JPH05255122A (en)
KR (1) KR930012037A (en)
AU (1) AU3021092A (en)
BR (1) BR9205071A (en)
CA (1) CA2085810A1 (en)
CZ (1) CZ375592A3 (en)
HU (1) HUT63342A (en)
IL (1) IL104164A0 (en)
NZ (1) NZ245526A (en)
PL (1) PL297065A1 (en)
RO (1) RO109035B1 (en)
SK (1) SK375592A3 (en)
ZA (1) ZA929830B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364483B2 (en) * 2014-06-20 2016-06-14 Laboratorios Virbac Pre-mix composition for cattle
CN114557259A (en) * 2022-03-03 2022-05-31 中国农业大学 Vegetable seedling culture medium containing high-activity growth-promoting bacteria and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS163505B1 (en) * 1972-11-15 1975-09-15
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
HU209473B (en) * 1990-12-22 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of fodder-additives, premixes and fodders containing n-thiobenzoil-morpholine derivatives with weight-gain increasing action

Also Published As

Publication number Publication date
JPH05255122A (en) 1993-10-05
BR9205071A (en) 1993-06-29
ZA929830B (en) 1993-06-23
IL104164A0 (en) 1993-05-13
RO109035B1 (en) 1994-11-30
PL297065A1 (en) 1993-07-26
HUT63342A (en) 1993-08-30
EP0549975A1 (en) 1993-07-07
CA2085810A1 (en) 1993-06-22
CZ375592A3 (en) 1994-02-16
HU9204027D0 (en) 1993-04-28
SK375592A3 (en) 1994-09-07
KR930012037A (en) 1993-07-20
AU3021092A (en) 1993-06-24

Similar Documents

Publication Publication Date Title
JP2012176949A (en) Use of vitamin d compound
Ingalls Influence of deoxynivalenol on feed consumption by dairy cows
BR102013016575A2 (en) PARTICULAR ANIMAL FEED SUPPLEMENTS WITH MEDICINAL PRODUCT AND METHODS FOR PREPARATION
CZ281620B6 (en) Pleuromutilin derivative and cyclodextrin complex, process of its preparation and a pharmaceutical composition in which said complex is comprised
Pérez et al. Contribution of dietary purine bases to duodenal digesta in sheep. In situ studies of purine degradability corrected for microbial contamination
NZ245526A (en) Pharmaceutical compositions and animal feedstuffs containing coarsely-particulate cereal bran as carrier
JP2021526149A (en) Formula containing iron with triadinone and low amounts of free iron ions
Swain et al. Effect of supplementation of combinations of different levels of selenium and vitamin E on relative weight of some organs and serum enzyme level in broilers
JP2952280B2 (en) Pig growth promotion
Dritz et al. Nutrient deficiencies and excesses
Abu Damir et al. The effects of feeding diets containing either NaHCO3 or NH4Cl on indices of bone formation and resorption and on mineral balance in the lamb
Alfaro et al. Effects of varying the amounts of dietary calcium on selenium metabolism in dairy calves
JP6403242B2 (en) Monensin water dispersible granules by wet granulation method
HU182652B (en) Process for producing food-additives containing antibiotics
KR100197451B1 (en) Semduramicin premix
CN109328020A (en) Composition and method for small-sized canid
Jones et al. Variation in the composition of barley and its effect on the performance of pigs
Dyer Symposium on Feed and Meats Terminology: I. Preparation of Feed for Animal Nutrition Experiments
Wood et al. 3-Phenylacetylamino-2, 6-piperidinedione inhibition of rat Nb2 lymphoma cell mitogenesis
Ko et al. Study on the development of the optimum feeding regimen for pigs weaned at 21 days of age
RAJAEIAN et al. Pharmacokinetics of tetracycline hydrochloride in fat-tailed sheep
Tenneson et al. Evaluation of vitamin content in ingredients and compound diets.
Hawton et al. High lysine corn for swine
Phillips et al. Effect of dietary supplements of vitamins A, D, and E on body burdens of DDT in the rat
Barwick Drug recovery from medicated animal feeds